Impact of Corticosteroids on Efficacy of BCMA Targeted CAR-T Therapy in Multiple Myeloma

被引：2
作者：
Duvalyan, Eva [1 ]
Lo, Mimi [2 ]
Martin, Thomas [3 ]
Wolf, Jeffrey L. [3 ]
Chung, Alfred [3 ]
Arora, Shagun [3 ]
Shah, Nina [3 ]
Huang, Chiung-Yu [3 ]
Wong, Sandy W. [3 ]
机构：
[1] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Pharmaceut Serv, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-146678
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1759
引用
收藏
页数：5
相关论文
共 50 条
  • [41] A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma
    Zhang, Hua
    Gao, Lei
    Liu, Li
    Wang, Jishi
    Wang, Sanbin
    Gao, Li
    Zhang, Cheng
    Liu, Yao
    Kong, Peiyan
    Liu, Jia
    He, Jiaping
    Han, Yu
    Shi, Hua
    He, Yan
    Ye, Xun
    Zhao, Yi
    Cao, Wei
    Shen, Lianjun
    Zhang, Xi
    BLOOD, 2019, 134
  • [42] Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
    Saldarriaga, Mateo Mejia
    Pan, Darren
    Unkenholz, Caitlin
    Mouhieddine, Tarek H.
    Velez-Hernandez, Juan Esteban
    Engles, Katherine
    Fein, Joshua A.
    Monge, Jorge
    Rosenbaum, Cara
    Pearse, Roger
    Jayabalan, David
    Gordillo, Christian
    Chan, Hei Ton
    Yamshon, Samuel
    Thibaud, Santiago
    Mapara, Markus
    Inghirami, Giorgio
    Lentzsch, Suzanne
    Reshef, Ran
    Rossi, Adriana
    Parekh, Samir
    Jagannath, Sundar
    Richard, Shambavi
    Niesvizky, Ruben
    Bustoros, Mark
    BLOOD ADVANCES, 2024, 8 (15) : 3859 - 3869
  • [43] Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in multiple myeloma
    Palacios-Berraquero, Maria Luisa
    Rodriguez-Marquez, Paula
    Calleja-Cervantes, Maria Erendira
    Berastegui, Nerea
    Zabaleta, Aintzane
    Burgos, Leire
    Alignani, Diego
    San Martin-Uriz, Patxi
    Vilas-Zornoza, Amaia
    Rodriguez-Diaz, Saray
    Inoges, Susana
    de Cerio, Ascension Lopez-Diaz
    Tamariz, Esteban
    Rifon, Jose
    Alfonso-Pierola, Ana
    Lasarte, Juan Jose
    Paiva, Bruno
    Hernaez, Mikel
    Rodriguez-Otero, Paula
    San-Miguel, Jesus
    Ezponda, Teresa
    Roberto, Juan
    Prosper, Felipe
    BLOOD ADVANCES, 2024, 8 (21) : 5479 - 5492
  • [44] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Samer Al Hadidi
    Aniko Szabo
    Jean Esselmann
    Lindsay Hammons
    Munawwar Hussain
    Yetunde Ogunsesan
    Nishanth Thalambedu
    Fatima Khan
    Jaskirat Sethi
    Abhishek Janardan
    Sabarinath Venniyil Radhakrishnan
    Sharmilan Thanendrarajan
    Carolina Schinke
    Binod Dhakal
    Siegfried Janz
    Saurabh Chhabra
    Anita D’Souza
    Maurizio Zangari
    Frits van Rhee
    Meera Mohan
    Bone Marrow Transplantation, 2023, 58 : 443 - 445
  • [45] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Al Hadidi, Samer
    Szabo, Aniko
    Esselmann, Jean
    Hammons, Lindsay
    Hussain, Munawwar
    Ogunsesan, Yetunde
    Thalambedu, Nishanth
    Khan, Fatima
    Sethi, Jaskirat
    Janardan, Abhishek
    Radhakrishnan, Sabarinath Venniyil
    Thanendrarajan, Sharmilan
    Schinke, Carolina
    Dhakal, Binod
    Janz, Siegfried
    Chhabra, Saurabh
    D'Souza, Anita
    Zangari, Maurizio
    van Rhee, Frits
    Mohan, Meera
    BONE MARROW TRANSPLANTATION, 2023, 58 (04) : 443 - 445
  • [46] Pseudoprogression in multiple myeloma patients treated with Anti-BCMA CAR-T cells
    Topp, Max
    Schimanski, Sven
    Hornburger, Hannah
    Kadel, Sophie
    Einsele, Hermann
    Rasche, Leo
    Duell, Johannes
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 146 - 146
  • [47] An alternative fully human anti-BCMA CAR-T shows response for relapsed or refractory multiple myeloma with anti-BCMA CAR-T exposures previously
    Wang, Qingming
    Wei, Runhong
    Guo, Shufang
    Min, Chao
    Zhong, Xiong
    Huang, Hui
    Cheng, Zhi
    CANCER GENE THERAPY, 2024, 31 (01) : 108 - 118
  • [48] Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma
    Sidana, Surbhi
    Hosoya, Hitomi
    Jensen, Alexandria
    Liu, Lawrence
    Goyal, Anmol
    Hovanky, Vanna
    Sahaf, Bita
    Bharadwaj, Sushma
    Latchford, Theresa
    Arai, Sally
    Leahy, Sheryl
    Mei, Matthew
    Budde, Lihua E.
    Muffly, Lori S.
    Frank, Matthew J.
    Dahiya, Saurabh
    Htut, Myo
    Miklos, David
    Janakiram, Murali
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [49] Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma
    Surbhi Sidana
    Hitomi Hosoya
    Alexandria Jensen
    Lawrence Liu
    Anmol Goyal
    Vanna Hovanky
    Bita Sahaf
    Sushma Bharadwaj
    Theresa Latchford
    Sally Arai
    Sheryl Leahy
    Matthew Mei
    Lihua E. Budde
    Lori S. Muffly
    Matthew J. Frank
    Saurabh Dahiya
    Myo Htut
    David Miklos
    Murali Janakiram
    Blood Cancer Journal, 13
  • [50] A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
    Mei, Heng
    Li, Chenggong
    Jiang, Huiwen
    Zhao, Xinying
    Huang, Zhiping
    Jin, Dan
    Guo, Tao
    Kou, Haiming
    Liu, Lin
    Tang, Lu
    Yin, Ping
    Wang, Zhihui
    Ai, Lisha
    Ke, Sha
    Xia, Yimeng
    Deng, Jun
    Chen, Lei
    Cai, Li
    Sun, Chunyan
    Xia, Linghui
    Hua, Gaoquan
    Hu, Yu
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
12345